Cogstate Ltd operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cogstate Ltd with three other companies in this sector in AUSTRALIA : Clinuvel Pharmaceuticals Limited (2020 sales of 33.13 million Australian Dollars [US$25.46 million] of which 100% was Biotechnology), Idt Australia Limited. (14.17 million Australian Dollars [US$10.89 million] ), and Mesoblast Ltd (47.97 million Australian Dollars [US$36.88 million] of which 100% was Adult Stem Cell Development).

Sales Analysis. During the second fiscal quarter of 2021, sales at Cogstate Ltd totalled A$19.00 million. This is an increase of 31.3% from the A$14.47 million in sales at the company during the second quarter of 2020. During the year ended June of 2020, sales at Cogstate Ltd were A$35.36 million (US$27.18 million). This is an increase of 15.6% versus 2019, when the company's sales were A$30.58 million. Despite this increase, sales are still below the level achieved in 2018, when Cogstate Ltd reported sales of A$37.49 million. Sales of Healthcare Market saw an increase that was more than double the company's growth rate: sales were up 745.8% in 2020, from A$414,691.60 to A$3.51 million. Cogstate Ltd also saw significant increases in sales in Research (up 50.0% to A$387,570.21 ) .